Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Propyl acetate | 500ml Pack Size. Group: Building Blocks, Organics, Solvents. Formula: CH3COOC3H7. CAS No. 109-60-4. Prepack ID : 90028291-500ml. Molecular Weight : 102.13. |  |
| 2-(1-Methoxy)propyl acetate | 2-(1-Methoxy)propyl acetate. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 108-65-6. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. Categories: 1-methoxy-2-propyl acetate. |  Cenik Chemicals |
| n-Propyl Acetate | n-Propyl Acetate. At Tan International we supply a wide range of products covering all industry sectors |  Scotland |
| n-Propyl Acetate | n-Propyl Acetate. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 109-60-4. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. | Cenik Chemicals |
| A37 | A37 is an aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor (IC50 = 4.6 μM; Ki = 300 nM). It competitively binds to the aldehyde binding pocket of ALDH1A1, resulting in the disruption of spheroid formation and a decrease of cell viability in ovarian cancer cells in vitro. Group: Pharmaceutical. Alternative Names: Ethyl 2-[[3,4-dihydro-4-oxo-3-[3-(1-pyrrolidinyl)propyl][1]benzothieno[3,2-d]pyrimidin-2-yl]thio]acetate; CM037; CM-037; CM 037; A37; A-37; A 37. CAS No. 896795-60-1. Pack Sizes: 1mg;1g;10g. Product ID: 896795-60-1. Molecular formula: C21H25N3O3S2. Mole weight: 431.57. Custom synthesis is available. Send your inquiries for more information. |  London |
| Acetyl-Phe1-octreotide Acetate | Acetyl-Phe1-octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanylD-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI); Ac-D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide Acetate. CAS No. 83795-62-4. Pack Sizes: 10 mg. Product ID: B1370-458988. Molecular formula: C51H68N10O11S2.xC2H4O2. Mole weight: 1061.28 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| D-Thr(6)-Octreotide Acetate | D-Thr(6)-0ctreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-,cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI). CAS No. 87759-90-8. Pack Sizes: 10 mg. Product ID: B1370-449813. Molecular formula: C49H66N10O10S2.xC2H4O2. Custom synthesis is available. Send your inquiries for more information. | London |
| Fingolimod EP Impurity H | Fingolimod EP Impurity H is an impurity of Fingolimod. Fingolimod is a novel immune modulator that prolongs allograft transplant survival in numerous models by inhibiting lymphocyte emigration from lymphoid organs. Group: Pharmaceutical. Alternative Names: 2-Acetoxymethyl-2-acetylamino-4-(4-octylphenyl)acetic Acid Butyl Ester; N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide; 2-acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate. CAS No. 162358-09-0. Pack Sizes: 1mg;1g;10g. Product ID: NP3661. Molecular formula: C25H39NO5. Mole weight: 433.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Octreotide Acetate | Octreotide acetate is a long-acting octapeptide with pharmacologic actions similars to the natural hormone somatostatin. It is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was approved as an injectable depot formulation used for acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors. It is a gastric antisecretory agent andcould inhibit the secretion of insulin and glucagon. It reduces production of IGF-1 and IGF-2 by the liver by modulation of growth-hormone secretion from the pituitary gland. It decreased the urinary excretion of uric acid as well as the plasma concentrations of glucagon and insulin. It decreased the urinary excretion of sodium and chloride without significiant influence on creatinine clearance, while the concentrations of lactic acid, pyruvic acid in blood, and cyclic AMP in plasma were not changed. It was first synthesized in 1979 by the chemist Wilfried Bauer and was developed by Novartis Pharmaceuticals. Uses: Antineoplastic agents, hormonal. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, acetate (1:x); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol.xCH3CO2H (Disulfide B | London |
| Zuclopenthixol acetate | Zuclopenthixol is a typical antipsychotic drug that belongs to thioxanthene class. Zuclopenthixol is the cis-isomer of clopenthixol. Zuclopenthixol has not been approved for use in the United States. It is a dopamine D1/D2 receptor antagonist used for the treatment of Schizophrenia. Uses: Schizophrenia. Group: Pharmaceutical. Alternative Names: (Z)-4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazine-1-ethyl acetate; Clopixol-Acuphase. CAS No. 85721-05-7. Pack Sizes: 1 g. Product ID: B1370-152978. Molecular formula: C24H27ClN2O2S. Mole weight: 443.01. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-(2,6-Dimethylhepta-1,5-dienyl)-4-methyl-1,3-dioxolane | 2-(2,6-Dimethylhepta-1,5-dienyl)-4-methyl-1,3-dioxolane, a chemical compound extensively employed in the production of fragrances and taste enhancers, has garnered attention for its potential as an insecticide, displaying efficacy in managing agricultural pests. This multipurpose compound's chemical structure and properties remain under scrutiny for its myriad potential applications in diverse fields. Group: Pharmaceutical. Alternative Names: Citral propylene glycol acetal; Geranial propylene glycol acetal; Citral, 1,2-propylene glycol acetal; 2-(2,6-Dimethyl-1,5-heptadienyl)-4-methyl-1,3-dioxolane; 1,3-Dioxolane, 2-(2,6-dimethyl-1,5-heptadienyl)-4-methyl-, (E)-; 1,3-Dioxolane, 2-((1E)-2,6-dimethyl-1,5-heptadien-1-yl)-4-methyl-. CAS No. 10444-50-5. Pack Sizes: 5 g. Product ID: B2699-087085. Molecular formula: C13H22O2. Mole weight: 210.31. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Acetonyl-3-hydroxyoxindole | 3-Hydroxy-3-acetonyloxindole is isolated from the herbs of Marsdenia tinctoria. Group: Pharmaceutical. Alternative Names: 33417-17-3;3-Hydroxy-3-acetonyloxindole;3-Hydroxy-3-(2-oxopropyl)-1,3-dihydro-2H-indol-2-one;3-Hydroxy-3-acetonyl-2-oxindole;3-hydroxy-3-(2-oxopropyl)-1H-indol-2-one;NSC 174507;1,3-Dihydro-3-hydroxy-3-(2-oxopropyl)-2H-indol-2-one;3-hydroxy-3-(2-oxopropyl)indolin-2-one;2-Indolinone,3-acetonyl-3-hydroxy-;3-Hydroxy-3-(2-oxo-propyl)-1,3-dihydro-indol-2-one;NSC659193;2H-INDOL-2-ONE, 1,3-DIHYDRO-3-HYDROXY-3-(2-OXOPROPYL)-;BRN 0182807;CBDivE_001774;3-acetonyl-3-hydroxyoxindole;4-21-00-06476 (Beilstein Handbook Reference);MLS000711569;CHEMBL1708591;SCHEMBL25435983;3-hydroxy-3-(2-oxopropyl)-2,3-dihydro-1H-indol-2-one;CBMTTXBZZZABGG-UHFFFAOYSA-N;DTXSID201036242;HMS2744D12;3-acetonyl-3-hydroxy-indolin-2-one;NSC174507;STK151695;STK846313;2-Indolinone, 3-acetonyl-3-hydroxy-;AKOS000274677;AKOS005626803;AKOS016038202;FS-8726;NSC-174507;NSC-659193;SDCCGMLS-0065646.P001;NCGC00245492-01;DA-48953;SMR000281336;1-(2,3-Dihydroxy-3H-indol-3-yl)acetone;CS-0017690;EN300-235764;1-(2,3-dihydroxy-3H-indol-3-yl)propan-2-one;2,3-Dihydroindole-3-ol-2-one, 3-acetomethyl-;SR-01000492393;SR-01000492393-1;Z56757977;F0896-0199;F1918-0060. CAS No. 33417-17-3. Pack Sizes: 1 mg. Product ID: NP0475. Molecular formula: C11H11NO3. Mole weight: 205.21. Custom synthesis is available. Send your inquiries for more information. | London |
| Ablukast | Ablukast, a specific and active leukotriene receptor antagonist, effectively reduces LTC4- and antigen-induced bronchoconstriction. It is an LTD4 receptor antagonist with anti-asthmatic effect. Group: Pharmaceutical. Alternative Names: Ro 23-3544; 6-Acetyl-7-(5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyloxy)-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid; 2H-1-Benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (±)-. CAS No. 96566-25-5. Pack Sizes: 1mg;1g;10g. Product ID: 96566-25-5. Molecular formula: C28H34O8. Mole weight: 498.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Acetophenazine | Acetophenazine, a phenothiazine derivative with antipsychotic, is used in the treatment of disorganized and psychotic thinking. Group: Pharmaceutical. Alternative Names: 1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]ethanone; Tindal; Acephenazinum; Acetophenazine. CAS No. 2751-68-0. Pack Sizes: 1mg;1g;10g. Product ID: 2751-68-0. Molecular formula: C23H29N3O2S. Mole weight: 411.561. Custom synthesis is available. Send your inquiries for more information. | London |
| Benazepril EP Impurity G | Benazepril EP Impurity G is an ethyl ester derivative of Benazepril, which is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Group: Pharmaceutical. Alternative Names: Benazepril Related Compound G; Benazepril USP Related Compound G; Benazepril ethyl ester; (S)-Ethyl 2-(((S)-1-(2-ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)amino)-4-phenylbutanoate; (3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic Acid ethyl Ester. CAS No. 103129-58-4. Pack Sizes: 25 mg. Product ID: B1370-151604. Molecular formula: C26H32N2O5. Mole weight: 452.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Cilengitide | Cilengitide is a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(V)beta(3) and alpha(V)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. It is being studied for the treatment of glioblastoma. Group: Pharmaceutical. Alternative Names: 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid. CAS No. 188968-51-6. Pack Sizes: 100 mg. Product ID: BAT-010773. Molecular formula: C27H40N8O7. Mole weight: 588.65. Custom synthesis is available. Send your inquiries for more information. | London |
| Compstatin | Compstatinis, a 13-residue cyclic peptide, is a potent inhibitor of the complement system (IC50= 12 μM) and binds to complement component C3. Group: Pharmaceutical. Alternative Names: H-Ile-Cys(1)-Val-Val-Gln-Asp-Trp-Gly-His-His-Arg-Cys(1)-Thr-NH2; L-isoleucyl-L-cysteinyl-L-valyl-L-valyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophyl-glycyl-L-histidyl-L-histidyl-L-arginyl-L-cysteinyl-L-threoninamide (2->12)-disulfide; 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-4-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-34-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-25-(3-amino-3-oxopropyl)-7-[3-(diaminomethylideneamino)propyl]-10,13-bis(1H-imidazol-5-ylmethyl)-19-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-28,31-di(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-22-yl]acetic acid. CAS No. 206645-99-0. Pack Sizes: 5 mg. Product ID: BAT-006096. Molecular formula: C66H99N23O17S2. Mole weight: 1550.77. Custom synthesis is available. Send your inquiries for more information. | London |
| DOTA-NOC | DOTA-NOC is a potent chelating agent extensively used in radiopharmaceuticals for the targeted imaging and therapy of neuroendocrine tumors. By combining with diverse radiometals, such as lutetium-177 or yttrium-90, it generates therapeutic agents that specifically bind to neuroendocrine tumor cells. The DOTA-NOC derivatives have displayed remarkable specificity and affinity for somatostatin receptors, endowing it with a unique potential for cancer therapy. Its diverse applications stem from its impressive properties, which include high burstiness in sentence structure and an elevated level of perplexity in its descriptions. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; DOTA-[Nal3]-octreotide; H-D-Phe(DOTA)-Cys(1)-Nal-D-Trp-Lys-Thr-Cys(1)-Thr-ol; DOTA-D-Phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide. CAS No. 619300-53-7. Pack Sizes: 1 mg. Product ID: B2699-192721. Molecular formula: C69H94N14O17S2. Mole weight: 1455.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Edotreotide | Edotreotide is a substance used in the treatment and diagnosis of certain types of cancer. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; (DOTA-D-Phe1,Tyr3)octreotide; DOTATOC; SDZ-SMT 487; SMT 487; SomaKit TOC; DOTA-(Tyr3)-Octreotide; SMT-487; SMT487; DOTA-d-Phe1-Tyr3-octreotide; DOTA-TOC. CAS No. 204318-14-9. Pack Sizes: 1 mg. Product ID: BAT-010135. Molecular formula: C65H92N14O18S2. Mole weight: 1421.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Fitusiran | Fitusiran, a small interfering RNA, specifically targets antithrombin (AT) messenger RNA to lower production of AT in the liver. It increases thrombin generation and has the potential for the research of the hemophilia. Group: Pharmaceutical. Alternative Names: ALN-AT3SC; SAR439774; RNA, ((2'-deoxy-2'-fluoro)G-sp-Gm-sp-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)A),3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-Dgalactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)U-sp-Gm-(2'-deoxy2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)A-Um-Gm-Gm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)C-Cm-sp-Am-sp-Gm). CAS No. 1499251-18-1. Pack Sizes: 1 mg. Product ID: B1370-072729. Custom synthesis is available. Send your inquiries for more information. | London |
| GalNac-L96 free base | GalNAC-L96 free base is a triantennary GalNAc ligand that can be used for the synthesis of GalNAC-SiRNA and for the delivery of nucleic acid drugs. GalNAc is a ligand for the asialal glycoprotein receptor (ASGPR). Group: Pharmaceutical. Alternative Names: L-96; Butanedioic acid, 1-[(3R,5S)-5-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-1-[1,12,19,25-tetraoxo-14,14-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-29-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-16-oxa-13,20,24-triazanonacos-1-yl]-3-pyrrolidinyl] ester; 1-[(3R,5S)-5-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-1-[1,12,19,25-tetraoxo-14,14-bis[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-29-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-16-oxa-13,20,24-triazanonacos-1-yl]-3-pyrrolidinyl] butanedioate; GalNAc-L96-SA; L-96-Succinic Acid; GalNAc-L96-Succinate. CAS No. 1159408-61-3. Pack Sizes: 100 mg. Product ID: B1370-427872. Molecular formula: C121H179N11O45. Mole weight: 2507.76. Custom synthesis is available. Send your inquiries for more information. | London |
| Givosiran sodium | Givosiran sodium is a small interfering RNA (siRNA) directed towards delta-aminolevulinate synthase 1 (ALAS1). Givosiran sodium has been indicated for the treatment of adults with acute hepatic porphyria (AHP). Group: Pharmaceutical. Alternative Names: ALN-AS1 sodium; ALN AS1 sodium; ALN-AS 1 sodium; WHO 10280 sodium; WHO-10280 sodium; WHO10280 sodium; Givlaari sodium; RNA, (Cm-sp-Am-sp-Gm-Am-Am-Am-(2'-deoxy-2'-fluoro)G-Am-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)C-Am-Um-Cm-Um-Um-Am), 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)G-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)U-Gm-sp-Gm-sp-Um) (1:1) sodium salt. Pack Sizes: 10 mg. Product ID: B1370-212888. Molecular formula: C524H651F16N173Na43O316P43S6. Mole weight: 17,245.56 Da. Custom synthesis is available. Send your inquiries for more information. | London |
| Inclisiran | Inclisiran is a medication approved for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk equivalents and heterozygous familial hypercholesterolemia (HeFH). It is a small interfering RNA (siRNA) that binds to PCSK9 messenger RNA, resulting in decreased concentrations of PCSK9 and plasma concentrations of LDL cholesterol. Group: Pharmaceutical. Alternative Names: ALN-PCSsc; ALN-60212; Leqvio; Inclisiran sodium; ALN-PCS; Leqvio; RNA, (Am-sp-(2'-deoxy-2'-fluoro)C-sp-Am-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)A-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)A-Gm-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)C-Um-Am-Gm-sp-Am-sp-Am), complex with RNA (Cm-sp-Um-sp-Am-Gm-Am-Cm-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)G-Um-dT-Um-Um-Gm-Cm-Um-Um-Um-Um-Gm-Um) 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] (1:1). CAS No. 1639324-58-5. Pack Sizes: 5 mg. Product ID: B1370-057828. Molecular formula: C529H707F12N176O316P43S6. Mole weight: 16339.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Integracin A | It is an unusual ester of two structurally related alkylresorcinols first isolated from fungus, cytonaema sp. It is a potent inhibitor of HIV-1. Group: Pharmaceutical. Alternative Names: Benzoic acid, 2-[(8R)-8-(acetyloxy)undecyl]-4,6-dihydroxy-, (1R)-8-(3,5-dihydroxyphenyl)-1-propyloctyl ester. CAS No. 224186-03-2. Pack Sizes: 1 mg. Product ID: BBF-04257. Molecular formula: C37H56O8. Mole weight: 628.84. Custom synthesis is available. Send your inquiries for more information. | London |
| lofepramine hydrochloride | Lofepramine is a tricyclic antidepressant (TCA) indicated for the treatment of depression. It functions via inhibiting 5-HT and NA reuptake. Group: Pharmaceutical. Alternative Names: N-(4-CHLOROBENZOYLMETHYL)-3-(10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPIN-5-YL)-N-METHYLPROPYLAMINE HYDROCHLORIDE; LOFEPRAMINE HCL; LOFEPRAMINE HYDROCHLORIDE; 4'-chloro-2-((3-(10,11-dihydro-5h-dibenz(b,f)azepin-5-yl)propyl)methylamino); acetophenone,4'-chloro-2-((3-(1. CAS No. 26786-32-3. Pack Sizes: 50 g. Product ID: B2693-064646. Molecular formula: C26H28Cl2N2O. Mole weight: 455.426. Custom synthesis is available. Send your inquiries for more information. | London |
| Lumasiran | Lumasiran is a siRNA product that reduces hepatic oxalate production by targeting glycolate oxidase. By silencing the gene encoding glycolate oxidase, Lumasiran depletes glycolate oxidase and thereby inhibits the synthesis of oxalate, which is the toxic metabolite that is directly associated with the clinical manifestations of Primary hyperoxaluria type 1 (PH1). Group: Pharmaceutical. Alternative Names: ALN-G01; RNA, (Gm-sp-Am-sp-Cm-Um-Um-Um-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Um-Gm-Gm-Am-Am-Am-Um-Am-Um-Am), 3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)A-sp-Um-Am-Um-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Am-Gm-Gm-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)A-Am-Am-Gm-Um-Cm-sp-Cm-sp-Am) (1:1). CAS No. 1834610-13-7. Pack Sizes: 5 mg. Product ID: B1370-072716. Molecular formula: C530H712F10N173O320P43S6. Mole weight: 16,340 Da. Custom synthesis is available. Send your inquiries for more information. | London |
| Lys(Ac)-Octreotide | Lys(Ac)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Uses: Radiopharmaceuticals. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys(Ac)-Thr-Cys-Thr-ol(Cys2&Cys7 bridge); N6.5-Acetyloctreotide; D-Phe-c(Cys-Phe-D-Trp-Lys(Ac)-Thr-Cys)-Thr-ol; Lys(Ac) 5 Octreotide; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl(acetyl)-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; Octreotide EP Impurity H; Octreotide Impurity H; Acetyl-Lys5-octreotide; D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-(N-acetyl)-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2→7)-disulfide. CAS No. 173606-11-6. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014750. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. Custom synthes | London |
| Montelukast EP Impurity E | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. Alternative Names: Montelukast USP Related Compound D; (R,S)-Montelukast Bis-sulfide; Montelukast R,S-Isomer; 2-(1-((((R)-1-(3-((S)-1-(((1-(carboxymethyl)cyclopropyl)methyl)thio)-2-(7-chloroquinolin-2-yl)ethyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropyl)acetic acid. CAS No. 1187586-58-8. Pack Sizes: 10 mg. Product ID: B2694-477814. Molecular formula: C41H46ClNO5S2. Mole weight: 732.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast EP Impurity I | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. Alternative Names: alpha hydroxy montelukast; Montelukast metabolite M7; [1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl](hydroxy)acetic Acid. CAS No. 2045402-27-3. Pack Sizes: 10 mg. Product ID: B1370-234661. Molecular formula: C35H36ClNO4S. Mole weight: 602.18. Custom synthesis is available. Send your inquiries for more information. | London |
| Olopatadine hydrochloride | Olopatadine HCl is a histamine blocker and mast cell stabilizer with an IC50 of 559 μM for the release of histamine. Uses: Anti-inflammatory agents, non-steroidal. Group: Pharmaceutical. Alternative Names: Pataday; Allelock; Patanase; Opatanol; (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid hydrochloride; Dibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-; (11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride; ALO 4943A; KW 4679. CAS No. 140462-76-6. Pack Sizes: 5 g. Product ID: NP3222. Molecular formula: C21H23NO3.HCl. Mole weight: 373.87. Custom synthesis is available. Send your inquiries for more information. | London |
| Seladelpar | Seladelpar is a selective peroxisome proliferator-activated receptor -δ receptor agonist. Phase II clinical trials for the treatment of Hyperlipidaemia, Hyperlipoproteinaemia type IIa and Primary biliary cirrhosis were on-going. Group: Pharmaceutical. Alternative Names: MBX8025; RWJ800025; MBX 8025; RWJ 800025; MBX-8025; RWJ-800025; (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic acid. CAS No. 851528-79-5. Pack Sizes: 100 mg. Product ID: B0084-476669. Molecular formula: C21H23F3O5S. Mole weight: 444.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Sevoflurane | Sevoflurane is an ether inhalation anaesthetic agent primarily used for the induction and maintenance of general anesthesia. It has been shown to enhance inhibitory postsynaptic channel activity (GABA and glycine), and inhibit excitatory synaptic channel activity (NMDA, nicotinic acetylcholine, serotonin, and glutamate) in the central nervous system. Group: Pharmaceutical. Alternative Names: Sevofluran; Ultane; 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl ester; Fluoromethyl 1,1,1,3,3,3-Hexafluoro-2-propyl ester. CAS No. 28523-86-6. Pack Sizes: 1mg;1g;10g. Product ID: 28523-86-6. Molecular formula: C4H3F7O. Mole weight: 200.1. Custom synthesis is available. Send your inquiries for more information. | London |
| TAK-448 | TAK-448 is a KISS1R protein agonist as a oligopeptide analog of kisspeptin. In animal model, TAK-448 can stimulate LH/FSH release, whereas continuous sc exposure rapidly down-regulates the pituitary-gonadal axis, with rapid reduction of T levels in a dose-dependent manner. Phase II clinical trials for the treatment of Prostate cancer was discontinued. In Dec 2016, Takeda terminated a phase II trial in Hypogonadism (In adults, In the elderly) in USA because the study did not meet the primary endpoints. Uses: Hypogonadism;prostate cancer. Group: Pharmaceutical. Alternative Names: MVT-602; Ac-D-Tyr-D-Trp-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2; RVT-602; RVT 602; TAK 448; RVT602; TAK448; N-acetyl-D-tyrosyl-(4R)-4-hydroxy-L-prolyl-L-asparaginyl-L-threonyl-L-phenylalanyl-2-azaglycyl-L-leucyl-N5-(imino(methylamino)methyl)-L-ornithyl-L-Tryptophanamide; Istaroxime; (2S,5S,8S,14S,17S,20S)-20-[({(2S,4R)-1-[(2R)-2-Acetamido-3-(4-hydroxyphenyl)propanoyl]-4-hydroxy-2-pyrrolidinyl}carbonyl)amino]-14-benzyl-17-(1-hydroxyethyl)-2-(1H-indol-3-ylmethyl)-8-isobutyl-5-[3-(N'-methylcarbamimidamido)propyl]-4,7,10,13,16,19-hexaoxo-3,6,9,11,12,15,18-heptaazadocosane-1,22-diamide. CAS No. 1234319-68-6. Pack Sizes: 25 mg. Product ID: BAT-010642. Molecular formula: C58H80N16O14. Mole weight: 1225.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Taxcultine | Taxol D is an impurity of Paclitaxel, an antineoplastic. It is used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Group: Pharmaceutical. Alternative Names: Baccatin III 13-ester with (2R,3S)-3-butanoylamino-2-hydroxy-3-phenylpropanoic acid; Paclitaxel Propyl analog; Benzenepropanoic acid, α-hydroxy-β-[(1-oxobutyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-; B. CAS No. 153415-46-4. Pack Sizes: 2.5 mg. Product ID: NP1480. Molecular formula: C44H53NO14. Mole weight: 819.89. Custom synthesis is available. Send your inquiries for more information. | London |
| Tralkoxydim | Tralkoxydim belongs to the cyclohexenone herbicide and is an inhibitor of acetyl-CoA carboxylase. Tralkoxydim is a highly selective herbicide that can effectively control a variety of grass weeds in wheat fields, including wild oats. Group: Pharmaceutical. Alternative Names: 2-Cyclohexen-1-one, 2-[1-(ethoxyimino)propyl]-3-hydroxy-5-(2,4,6-trimethylphenyl)-; 2-[1-(Ethoxyimino)propyl]-3-hydroxy-5-(2,4,6-trimethylphenyl)-2-cyclohexen-1-one; 2-[1-(Ethoxyimino)propyl]-3-hydroxy-5-mesitylcyclohex-2-enone; Achieve; Achieve (pesticide); FD 4026; Grasp; Grasp (cyclohexenone); ICI-A 604; ICIA 0604; PP 604; Splendor. CAS No. 87820-88-0. Pack Sizes: 1mg;1g;10g. Product ID: 87820-88-0. Molecular formula: C20H27NO3. Mole weight: 329.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Tri-GalNAc(OAc)3 | Tri-GalNAc(OAc)3 is a modified glycosylated compound that features three N-acetylgalactosamine (GalNAc) units, and is typically provided as a trifluoroacetic acid (TFA) salt. This structure enhances the compound's solubility and stability, making it suitable for use in various biological applications, including drug delivery and targeted therapeutics. The presence of multiple acetyl groups can improve the bioavailability and cellular uptake of the compound, while the tri-GalNAc configuration allows for specific interactions with receptors, particularly in the context of glycoengineering and the development of therapies for conditions like cancer and genetic disorders. It is a molecular building block belonging to the GalNAc series or related delivery systems. Tri-GalNAc(OAc)3 TFA is a tri-GalNAc ligand that can be used for the synthesis of GalNAc-LYTAC. Group: Pharmaceutical. Alternative Names: Peracetylated GalNAc-L96-Amine; Peracetylated tri-GalNAc-amine; 6-Amino-11,17-dioxo-6-[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-N-[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]-21-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy. CAS No. 1159408-64-6. Pack Sizes: 25 mg. Product ID: B1370-098387. Molecular formula: C79H128N10O36. Mole weight: 1793. | London |
| Tri-GalNAc(OAc)3 TFA | Tri-GalNAc(OAc)3 TFA is a modified glycosylated compound that features three N-acetylgalactosamine (GalNAc) units, and is typically provided as a trifluoroacetic acid (TFA) salt. This structure enhances the compound's solubility and stability, making it suitable for use in various biological applications, including drug delivery and targeted therapeutics. The presence of multiple acetyl groups can improve the bioavailability and cellular uptake of the compound, while the tri-GalNAc configuration allows for specific interactions with receptors, particularly in the context of glycoengineering and the development of therapies for conditions like cancer and genetic disorders. It is a molecular building block belonging to the GalNAc series or related delivery systems. Tri-GalNAc(OAc)3 TFA is a tri-GalNAc ligand that can be used for the synthesis of GalNAc-LYTAC. Group: Pharmaceutical. Alternative Names: Peracetylated tri-GalNAc-amine TFA salt; 4,8-Dioxa-12,16-diazaheneicosanamide, 6-amino-11,17-dioxo-6-[[3-oxo-3-[[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]amino]propoxy]methyl]-N-[3-[[1-oxo-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]pentyl]amino]propyl]-21-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galac. CAS No. 1159408-65-7. Pack Sizes: 100 mg. Product ID: B1370-427874. Molecular formula: C81H129F3N10O38. Mole we | London |
Our database is helping our users find suppliers everyday.
